title: PP2A(Cdc55/B55), a possible therapeutic target in cyclin D1-dependent cancers.
authors: Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA. enoguchi@drexelmed.edu
authors: Eishi
authors: E
authors: Noguchi
mesh_terms: D002453:Cell Cycle / Q000502:physiology*; D018797:Cell Cycle Proteins / Q000378:metabolism*; D056766:Cyclin G1 / Q000378:metabolism*; D016213:Cyclins / Q000378:metabolism*; D054648:Protein Phosphatase 2 / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000502:physiology*; D029701:Saccharomyces cerevisiae Proteins / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D056766:Cyclin G1; D016213:Cyclins; D029701:Saccharomyces cerevisiae Proteins; D054648:Protein Phosphatase 2
keywords: PP2A; SCF; cancer therapy; cell cycle; cyclin D1; genomic integrity; phosphatase; protein degradation; ubiquitin ligase
references: Cell Div. 2007 Jan 15;2:2
references: 17224055
references: Cancer Lett. 2013 Jul 10;335(1):9-18
references: 23454242
references: Science. 1996 Mar 15;271(5255):1597-601
references: 8599119
references: Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11697-702
references: 19564615
references: Anticancer Agents Med Chem. 2011 Jan;11(1):38-46
references: 21288198
references: Trends Biochem Sci. 2012 Feb;37(2):66-73
references: 22099186
references: Cell Cycle. 2013 Apr 15;12(8):1201-10
references: 23518505
references: Nat Rev Cancer. 2011 Jul 07;11(8):558-72
references: 21734724